| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11864-011-0151-7 |
| P698 | PubMed publication ID | 21445576 |
| P50 | author | H. Richard Alexander | Q123195986 |
| P2093 | author name string | Sheelu Varghese | |
| Keli M Turner | |||
| P2860 | cites work | Prospective trial for the treatment of malignant peritoneal mesothelioma | Q74625291 |
| Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma | Q78170268 | ||
| Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma | Q79318936 | ||
| Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma | Q80980814 | ||
| Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin | Q84116806 | ||
| Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials | Q84624651 | ||
| Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer | Q28293019 | ||
| Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. | Q33196736 | ||
| Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group | Q33390297 | ||
| Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. | Q33489828 | ||
| A review of peritoneal mesothelioma at the Washington Cancer Institute | Q34271017 | ||
| Peritonectomy procedures | Q34316366 | ||
| Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. | Q34543902 | ||
| Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma | Q34562049 | ||
| Epidemiology of peritoneal mesothelioma: a review | Q34572643 | ||
| The relationship between simian virus 40 and mesothelioma. | Q34783984 | ||
| Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. | Q35563249 | ||
| The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies | Q35563252 | ||
| Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. | Q35563258 | ||
| Systemic chemotherapy in the management of malignant peritoneal mesothelioma. | Q36450227 | ||
| Comprehensive management of diffuse malignant peritoneal mesothelioma | Q36452199 | ||
| Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma | Q36882809 | ||
| Peritoneal mesotheliomas: clinicopathologic features, CT findings, and differential diagnosis. | Q37248252 | ||
| Consensus statement on peritoneal mesothelioma. | Q37252035 | ||
| Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma. | Q39656146 | ||
| Clinical presentation of peritoneal mesothelioma | Q40552733 | ||
| Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program | Q42664910 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. | Q43703526 | ||
| A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*. | Q43847427 | ||
| Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. | Q44055675 | ||
| Early peritoneal mesothelioma: a treatable malignancy | Q44560697 | ||
| Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial | Q46473448 | ||
| Lymph node metastases in diffuse malignant peritoneal mesothelioma. | Q46599379 | ||
| Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. | Q51798012 | ||
| Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. | Q53599026 | ||
| Mesothelin-family proteins and diagnosis of mesothelioma | Q57297479 | ||
| Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion | Q61794224 | ||
| Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study | Q64046989 | ||
| Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience | Q64049138 | ||
| Diagnosis of peritoneal mesothelioma: computed tomography, sonography, and fine-needle aspiration biopsy | Q70987743 | ||
| Multimodality therapy for malignant mesothelioma based on a study of natural history | Q71152015 | ||
| Peritoneal mesothelioma: natural history and response to chemotherapy | Q71186841 | ||
| Results of treatment of 33 patients with peritoneal mesothelioma | Q73223272 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 189-200 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Current Treatment Options in Oncology | Q3510796 |
| P1476 | title | Surgery for peritoneal mesothelioma. | |
| P478 | volume | 12 |
Search more.